Wednesday, September 3, 2008

Antiangiogenic And Anti-Inflammatory Drugs: Are They Safe?

Antiangiogenic And Anti-Inflammatory Drugs: Are They Safe?
Since Rofecoxib (Vioxx) was withdrawn from the worldwide market based on the safety findings of the Adenomatous Polyp Prevention on Vioxx (APPROVe) study, the uncertainty around the cardiovascular safety of NSAIDs and COX-2 inhibitors remains and leaves practitioners with difficult management decisions for the hundreds of millions of patients worldwide who continue to require pain-relieving therapy to maintain an acceptable quality of life.

Exercise Beneficial For Individuals At Risk Of Dementia
A study published in the September 3 issue of JAMA reports that cognitive function modestly improved in adults suffering with memory problems who participated in a home-based physical activity program compared to those who did not participate in the program. Alzheimer disease (AD) affects 26.6 million people worldwide and is expected to affect 106.2 million by 2050 as the world population increases. Nicola T. Lautenschlager, M.D.

Networks For Life
Implementation of networks among medical emergency services, ambulances, and hospital of different technological levels, in a hub-and-spoke framework, provides the best results and an equitable access to timely care for all patients with acute myocardial infarction (STEMI type).

Fibrin Derived Peptide FX06 Reduces Cardiac Reperfusion Injury
Data presented at the European Society of Cardiology Congress demonstrates the effectiveness of a peptide called FX06 in preventing cardiac damage resulting from treatment following a heart attack. While reperfusion is well established as a standard of care, it paradoxically causes additional damage to heart muscle in patients surviving from these attacks a phenomenon termed "reperfusion injury". FX06 is a novel compound intended to prevent that damage.

B-Vitamin Deficiency May Cause Vascular Cognitive Impairment
A deficiency of B-vitamins may cause vascular cognitive impairment, according to a new study. Researchers at the Jean Mayer USDA Human Nutrition Research Center on Aging (HNRCA) at Tufts University used an experimental model to examine the metabolic, cognitive, and microvascular effects of dietary B-vitamin deficiency. Their findings appear in Proceedings of the National Academy of Sciences (PNAS).

Yes - There is Natural Relief From the Sick and Tiredness of Hepatitis C

Many people who have Hepatitis C suffer from chronic tiredness. They often feel discouraged and overwhelmed and can become irritable and depressed. These symptoms tend to dig in and get worse over time as the mental and emotional states reinforce the physical ones, and vice versa. Conventional therapy is more or less confined to drugs based on interferon that don't work particularly well and usually have devastating side effects. Understandably, for many sufferers, it can seem like there is no way out from the sick-and-tiredness of it all.